Valeant Pharmaceuticals To Present At Industry Conference

LAVAL, Quebec, Nov. 12, 2015 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that members of its senior management team will be presenting at the Jefferies Autumn 2015 Global Healthcare Conference in London, UK. 

Valeant will present on Wednesday, November 18, 2015 between 1:20 p.m. – 2:00 p.m. GMT (8:20 a.m. – 9:00 a.m. ET) at The May Fair Hotel.

A live webcast and audio archive of the presentation will be available on Valeant's corporate website on the "Investor Relations" page, under the "Events and Presentations" tab and via this URL: http://ir.valeant.com/investor-relations/events-and-presentations/default.aspx 

Participants are encouraged to allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the webcast.

About Valeant 

Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorder, eye health, neurology and branded generics. More information about Valeant and forward looking statements can be found at www.valeant.com.

Contact Information:
Laurie W. Little
949-461-6002
[email protected]

Elif McDonald
905-695-7607
[email protected]

Media:
Renee E. Soto/Meghan Gavigan
Sard Verbinnen & Co.
212-687-8080
[email protected] / [email protected]

Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO

SOURCE Valeant Pharmaceuticals International, Inc.